Lindh E, Björk I
Eur J Biochem. 1976 Feb 16;62(2):271-8. doi: 10.1111/j.1432-1033.1976.tb10157.x.
The binding of human free secretory component to immoglobulin M (IgM) has been studied in vitro as a model for the formation of complexes between the two proteins in vivo. Three IgM myelomas and normal serum IgM were found to bind secretory component in amounts from 0.8 to 2.0 mol per mol of IgM. This variation in binding was not related to a corresponding variation of the J-chain content of the immunoglobulins, but more likely it was due to varying amounts of unspecifically bound serum proteins blocking the attachment of secretory component. In contrast to complexes with immunoglobulin A (IgA), the binding of secretory component to IgM appeared to be solely of a noncovalent nature, as all secretory component was released from complexes with IgM during gel chromatography in 6 M guanidine hydrochloride. Studies with tryptic fragments of one of the IgM myelomas indicated that the binding site for secretory component is located on the (Fc)5mu part of the IgM pentamer. Finally, only minimal conformational changes were found to accompany complex formation between secretory component and IgM, analogous to what has earlier been reported for the attachment of the secretory component to IgA.
人体游离分泌成分与免疫球蛋白M(IgM)的结合已在体外进行研究,以此作为体内两种蛋白质之间形成复合物的模型。研究发现,三种IgM骨髓瘤蛋白和正常血清IgM结合分泌成分的量为每摩尔IgM 0.8至2.0摩尔。这种结合的差异与免疫球蛋白J链含量的相应变化无关,而更可能是由于非特异性结合的血清蛋白量不同,从而阻断了分泌成分的附着。与免疫球蛋白A(IgA)复合物不同,分泌成分与IgM的结合似乎完全是非共价性质的,因为在6M盐酸胍的凝胶色谱过程中,所有分泌成分都从与IgM的复合物中释放出来。对其中一种IgM骨髓瘤蛋白的胰蛋白酶片段研究表明,分泌成分的结合位点位于IgM五聚体的(Fc)5μ部分。最后,发现分泌成分与IgM形成复合物时仅伴随最小程度的构象变化,这与之前报道的分泌成分与IgA结合的情况类似。